ScholarWorks@SUNGKYUNKWAN UNIVERSITY: SEOL, HO JUN

Detailed Information

SEOL, HO JUN (설호준)

Medicine (Medicine)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Glioblastoma:13||Stereotactic radiosurgery:10||Gamma knife radiosurgery:8||Radiosurgery:7||glioblastoma:7||Temozolomide:6||Recurrence:6||Radiotherapy:5||Brain metastases:4||Gamma knife:4||Oncology:4||Irinotecan:3||Endoscopic surgery:3||Gamma Knife radiosurgery:3||Highgrade glioma:3||glioma:3||Pituitary adenoma:3||Cavernous sinus:3||oncology:3||Endoscopic endonasal surgery:3||Cerebrospinal fluid leak:2||temozolomide:2||Glioblastoma multiforme:2||Facial palsy:2||Brain metastasis:2||Vestibular schwannoma:2||Visual outcome:2||invasion:2||Endoscopic:2||Pituitary surgery:2||Endoscopic endonasal approach:2||Leptomeningeal seeding:2||Precision medicine:2||migration:2||Lowgrade glioma:2||Gamma Knife:2||MGMT:2||Survival:2||Asymptomatic meningioma:2||Machine learning:2||Nonsmall cell lung cancer:2||Magnetic resonance imaging:2||endoscopic endonasal approach:2||CNS lymphoma:2||endoscopic transorbital approach:2||Metastasis:2||Optic coherence tomography:2||Metastatic brain tumor:2||Carboxyl esterase (CE):2||DNA damage response:1||Daily life:1||Deepseated:1||Disease progression:1||Docking:1||Dorsum sellar resection:1||Doseescalation study:1||EGFR:1||EOT:1||Elderly:1||Endonasal:1||Endonasal transpterygoid:1||Endoscope:1||Endoscopic transorbital approach:1||Endoscopic transsphenoidal surgery:1||Extracranial metastasis:1||Facial Nerve:1||Facial nerve preservation surgery:1||Fractionated Gamma Knife radiosurgery:1||Fractionated radiosurgery:1||Fractionated stereotactic radiosurgery:1||Fractionation schedule:1||GBM:1||Ga:1||Gamma Knife Radiosurgery:1||Gamma knife surgery:1||Gene expression profiling:1||Genome:1||Giant solid hemangioblastoma:1||Glioblastoma multiforme (GBM):1||Glioma:1||Hearing:1||Hemangioblastoma:1||Hemangiopericytoma:1||Hormonal recovery:1||Hormone replacement therapy:1||Hydrocephalus:1||Hyperprolactinemia:1||Hypopituitarism:1||IDH1:1||Injectable hydroxyapatite:1||Interfraction interval:1||Intratumoral heterogeneity:1||Intracranial metastases:1||Intracranial pressure:1||Intrathecal
chemotherapy:1||Intraventricular tumor:1||Irradiation:1||Isocitrate dehydrogenase:1||Jugular foramen:1||Kras:1||Large vestibular schwannoma:1||Leptomeningeal spread:1||Lowlying chiasm:1||Lumbar drainage:1||Lung cancer:1||MRI:1||Malignant glioma:1||Malignant gliomas · Neuronal marker · Methylation status of O6methylguanineDNA methyltransferase · Expression of isocitrate dehydrogenase 1 · 1p and 19q.:1||Meckel’s cave:1||Meningioma:1||Methylation:1||Microarray analysis:1||Microsurgery:1||Microsurgical:1||Microsurgical resection:1||Middle cranial fossa:1||Middle fossa tumors:1||Mitochondrial permeability transition pore (mPTP):1||Multicentric:1||Multilayer technique:1||Mutation:1||Natural history:1||Navigation:1||Neoplasm metastasis:1||Neural stem cells:1||Neuroendoscopic surgery:1||Neuroendoscopy:1||Neurofibromatosis type 2:1||Neuronavigation:1||Nonfunctioning pituitary adenomas:1||Nonsmall cell lung cancer · EGFR · Kras · ALK · Gamma knife radiosurgery:1||Nonsmallcell lung:1||Nonfunctioning:1||Nonfunctioning pituitary adenoma:1||O6methylguanineDNA methyltransferase:1||O6methylguaninDNA m:1||Optical coherence tomography:1||Orbital cavernous venous malformation:1||PCV:1||Patterns of care:1||Pediatric:1||Perfusion MRI:1||Pharmacogenomics:1||Phenotypes:1||Phosphorylated Chk1 (PChk1):1||Pituitary gland:1||Postoperative:1||Postoperative radiotherapy:1||Postural change:1||Primary treatment:1||Proactive Gamma Knife surgery:1||Prognosis:1||Programmed cell death 1 receptor:1||Prolactinoma:1||Propensity score matching:1||Quantitative imaging:1||Quinazolineurea:1||Rabbit:1||Radiation:1||Radiation necrosis:1||Radiation therapy:1||Radiogenomic:1||Radiomic:1||Radiomics:1||Radioresistance:1||Radioresistant:1||Reconstructive outcome:1||Recurrent:1||Relative cerebral blood volume:1||Response assessment:1||Retinal nerve fiber layer:1||Retrochiasmatic:1||Retroinfundibular:1||Retrosigmoid:1||Retrosigmoid approach:1||Risk factor:1||Risk factors:1||Salvage treatment:1||Schwannoma:1||Simpson grading system:1||Sinonasal pressure:1||Skull base:1||Skull base malignancy:1||Skull base surgery:1||Skull base tumor:1||Surgical approach:1||Surgical bed:1||Surgical technique:1||Targeted sequencing:1||Threefraction gamma knife radiosurgery:1||Time to return:1||TopBP1:1||Topography:1||Toxicity profile:1||Transsphenoidal approach:1||Transsphenoidal surgery:1||Transglutaminase 2:1||Translabyrinthine:1||Translocator protein 18 kDa (TSPO):1||Transorbital:1||Transorbital approach:1||Transsphenoidal surgeryp:1||Tubular retractor:1||Tumor Volume:1||Tumor bed:1||Tumor laterality:1||Tumor suppressor protein p53:1||Tumor volume:1||Twostaged gamma knife surgery:1||Upper clivus:1||Vestibular Schwannoma:1||WHO grade:1||Without hydrocephalus:1||adolescents:1||amoeboid:1||anaplastic largecell:1||approach:1||astrocytoma:1||bevacizumab:1||biomarker:1||biomarkers:1||brain location:1||cancer genomics:1||carboxyl esterase (CE):1||castration resistance:1||cerebellar glioblastoma:1||cerebrospinal fluid leak:1||chemotherapy:1||children:1||cofilin:1||cranioorbital tumor:1||endoscope:1||endoscopic:1||endoscopic endonasal surgery:1||endoscopic surgery:1||ethnic:1||extracranial metastasis:1||gamma knife radiosurgery:1||gene expression signatures:1||genetics:1||genomic profiling:1||genomics:1||glioblastoma stem cell:1||glioblastoma subclassification:1||glioma stem cells:1||grosstotal resection:1||growth factor:1||hemangiopericytoma:1||hepatocyte g:1||hydrocephalus:1||hydroxyapatite:1||hypermutation:1||hypofractionation:1||intracranial schwannoma:1||leptomeningeal dissemination:1||leptomeningeal enhancement:1||lymphopenia:1||meningioma:1||mesenchymal:1||metastasis:1||mismatch repair deficiency:1||moyamoya disease:1||multilayer technique:1||neoantigenicity:1||neural stem cells:1||optic nerve:1||orbital tumors:1||outcome:1||pathological grade:1||pediatric:1||personalized medicine:1||petrous apex:1||phosphorylation:1||pituitary surgery:1||primary:1||progression:1||prostate cancer:1||rabbit:1||radiation therapy:1||radiogenomic analysis:1||radiogenomics:1||radiomics:1||radiotherapy:1||risk factor:1||secondary neuralgia:1||shortterm cultivation screening platform:1||skull base reconstruction:1||skull base surgery:1||solitary fibrous tumor:1||surgery:1||surgical technique:1||transcranial:1||translabyrinthine surgery:1||transorbital surgery:1||trigeminal neuralgia:1||tuberculum sellae:1||tumor progression locus 2:1||unilateral moyamoya disease:1||use infiltrating glioma:1||vestibular schwannoma:1||1p19q:1||visual outcome:1||2SGKR:1||ADC:1||ALK:1||ALKpositive:1||ATM:1||Activity of daily living:1||Acute obstructive hydrocephalus:1||Adjuvant treatment:1||Alltrans retinoic acid:1||Anaplastic gliomas:1||Angiogenesis:1||Angiomatous meningioma:1||Bevacizumab:1||Bexarotene:1||Biomarkers:1||Boost:1||Brain edema:1||Brain tumor:1||CD151:1||CD99:1||CNS:1||CPT11:1||Cancer genomics:1||Cancer of the uterine cervix:1||Cancer panel:1||Carcinoma:1||Carcinoma, Nonsmallcell lung:1||Cavernous sinus invasion:1||Central neurocytoma:1||Cerebellar injury:1||Cerebellopontine angle tumor:1||Chemoradiotherapy:1||Chemotherapy:1||Chondrosarcoma:1||Chordoma:1||Classification:1||Clivus:1||Clonogenic assay:1||Combined approach:1||Combined endoscopic surgery:1||Complication:1||Conventional Treatment:1||Cranial nerve:1||Craniopharyngioma:1||Craniotomy:1||Crizotinib:1||DNA damage:1||DNA damage checkpoint:1||

STATISTICS: Total View :5,176,715; Today View :0

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE